262 related articles for article (PubMed ID: 12600195)
21. Conformational studies of parathyroid hormone (PTH)/PTH-related protein (PTHrp) chimeric peptides.
Schievano E; Mammi S; Silvestri L; Behar V; Rosenblatt M; Chorev M; Peggion E
Biopolymers; 2000 Nov; 54(6):429-47. PubMed ID: 10951329
[TBL] [Abstract][Full Text] [Related]
22. Ligand-receptor interactions at the parathyroid hormone receptors: subtype binding selectivity is mediated via an interaction between residue 23 on the ligand and residue 41 on the receptor.
Mann R; Wigglesworth MJ; Donnelly D
Mol Pharmacol; 2008 Sep; 74(3):605-13. PubMed ID: 18539702
[TBL] [Abstract][Full Text] [Related]
23. Bioactivities and secondary structures of constrained analogues of human parathyroid hormone: cyclic lactams of the receptor binding region.
Barbier JR; Neugebauer W; Morley P; Ross V; Soska M; Whitfield JF; Willick G
J Med Chem; 1997 Apr; 40(9):1373-80. PubMed ID: 9135034
[TBL] [Abstract][Full Text] [Related]
24. Analysis of parathyroid hormone (PTH)/secretin receptor chimeras differentiates the role of functional domains in the pth/ pth-related peptide (PTHrP) receptor on hormone binding and receptor activation.
Vilardaga JP; Lin I; Nissenson RA
Mol Endocrinol; 2001 Jul; 15(7):1186-99. PubMed ID: 11435617
[TBL] [Abstract][Full Text] [Related]
25. Human growth hormone-releasing hormone hGHRH(1-29)-NH2: systematic structure-activity relationship studies.
Cervini LA; Donaldson CJ; Koerber SC; Vale WW; Rivier JE
J Med Chem; 1998 Feb; 41(5):717-27. PubMed ID: 9513600
[TBL] [Abstract][Full Text] [Related]
26. Regions in rat and human parathyroid hormone (PTH) 2 receptors controlling receptor interaction with PTH and with antagonist ligands.
Goold CP; Usdin TB; Hoare SR
J Pharmacol Exp Ther; 2001 Nov; 299(2):678-90. PubMed ID: 11602681
[TBL] [Abstract][Full Text] [Related]
27. Mono- and bicyclic analogs of parathyroid hormone-related protein. 1. Synthesis and biological studies.
Bisello A; Nakamoto C; Rosenblatt M; Chorev M
Biochemistry; 1997 Mar; 36(11):3293-9. PubMed ID: 9116007
[TBL] [Abstract][Full Text] [Related]
28. Structure and function of a minimal receptor activation domain of parathyroid hormone.
Lee EJ; Kim HY; Cho MK; Lee W; Lim SK
Yonsei Med J; 2004 Jun; 45(3):419-27. PubMed ID: 15227728
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and structural studies of new analogues of PTH(1-11) containing Cα-tetra-substituted amino acids in position 8.
Caporale A; Sturlese M; Schievano E; Mammi S; Peggion E
Amino Acids; 2010 Nov; 39(5):1369-79. PubMed ID: 20431900
[TBL] [Abstract][Full Text] [Related]
30. C-terminal analogues of parathyroid hormone: effect of C-terminus function on helical structure, stability, and bioactivity.
Potetinova Z; Barbier JR; Suen T; Dean T; Gardella TJ; Willick GE
Biochemistry; 2006 Sep; 45(37):11113-21. PubMed ID: 16964972
[TBL] [Abstract][Full Text] [Related]
31. Analysis of parathyroid hormone's principal receptor-binding region by site-directed mutagenesis and analog design.
Gardella TJ; Wilson AK; Keutmann HT; Oberstein R; Potts JT; Kronenberg M; Nussbaum SR
Endocrinology; 1993 May; 132(5):2024-30. PubMed ID: 8386605
[TBL] [Abstract][Full Text] [Related]
32. Orientation, positional, additivity, and oligomerization-state effects of interhelical ion pairs in alpha-helical coiled-coils.
Kohn WD; Kay CM; Hodges RS
J Mol Biol; 1998 Nov; 283(5):993-1012. PubMed ID: 9799639
[TBL] [Abstract][Full Text] [Related]
33. Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges.
Koerber SC; Gulyas J; Lahrichi SL; Corrigan A; Craig AG; Rivier C; Vale W; Rivier J
J Med Chem; 1998 Dec; 41(25):5002-11. PubMed ID: 9836618
[TBL] [Abstract][Full Text] [Related]
34. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
35. Conformational studies of parathyroid hormone (PTH)/PTH-related protein (PTHrP) point-mutated hybrids.
Peggion E; Mammi S; Schievano E; Behar V; Rosenblatt M; Chorev M
Biopolymers; 1999 Oct; 50(5):525-35. PubMed ID: 10479735
[TBL] [Abstract][Full Text] [Related]
36. Conformational and biological characterization of human parathyroid hormone hPTH(1-34) analogues containing beta-amino acid residues in positions 17-19.
Schievano E; Mammi S; Carretta E; Fiori N; Corich M; Bisello A; Rosenblatt M; Chorev M; Peggion E
Biopolymers; 2003 Dec; 70(4):534-47. PubMed ID: 14648764
[TBL] [Abstract][Full Text] [Related]
37. Histamine-releasing activity and binding to the FcepsilonRI alpha human mast cell receptor subunit of mast cell degranulating peptide analogues with alanine substitutions.
Buku A; Mendlowitz M; Condie BA; Price JA
J Med Chem; 2003 Jul; 46(14):3008-12. PubMed ID: 12825939
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo activities of C-terminally truncated PTH peptides reveal a disconnect between cAMP signaling and functional activity.
Murrills RJ; Matteo JJ; Samuel RL; Andrews JL; Bhat BM; Coleburn VE; Kharode YP; Bex FJ
Bone; 2004 Dec; 35(6):1263-72. PubMed ID: 15589208
[TBL] [Abstract][Full Text] [Related]
39. Structural/functional characterization of the alpha 2-plasmin inhibitor C-terminal peptide.
Frank PS; Douglas JT; Locher M; Llinás M; Schaller J
Biochemistry; 2003 Feb; 42(4):1078-85. PubMed ID: 12549929
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the human and mouse genes encoding the tuberoinfundibular peptide of 39 residues, a ligand of the parathyroid hormone receptor family.
Hansen IA; Jakob O; Wortmann S; Arzberger T; Allolio B; Blind E
J Endocrinol; 2002 Jul; 174(1):95-102. PubMed ID: 12098667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
